Meningococcal disease in Norway 1992-1995. Epidemiology and fatality

被引:28
作者
Iversen, BG
Aavitsland, P
机构
[1] National Institute of Public Health, Oslo
[2] National Institute of Public Health, Box 4404 Torshov
关键词
D O I
10.3109/00365549609027167
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We analysed data on all cases of meningococcal disease (MCD) reported to the Norwegian Notification System for Infectious Diseases during the period 1992-1995. For 1994, additional information on fatalities was gathered. Notifications were received from laboratories and clinicians. A total of 586 patients were included. The incidence decreased from 4.6 per 100 000 in 1992 to 2.4 in 1994, and then rose to 3.7 in 1995. The initial decrease, a trend also observed in previous years, was seen in both main serogroups B and C. This decline was broken with the increase of serogroup B in 1995. MCD predominantly affects children below 5 years and teenagers. In 1994, 17/105 (16%) patients died. Main risk factors for fatal outcome were age above 30 gears (adjusted odds ratio (OR) 19.8; 95% confidence interval (CI) 2.4-164), septicaemia (adjusted OR 9.5; 95% CI 2.2-41) and disease caused bg strains B:15 (adjusted OR 6.4; 95% CI 1.2-35) or C:2a (adjusted OR 10.1; 95% CI 1.6-62). We conclude that the incidence of MCD in Norway is unpredictable and that the case fatality rate is substantially higher than previously believed.
引用
收藏
页码:253 / 259
页数:7
相关论文
共 32 条
[1]   MORTALITY IN MENINGOCOCCAL INFECTIONS [J].
ANDERSEN, BM .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1978, 10 (04) :277-282
[2]  
BAY D, 1983, NIPH (National Institute of Public Health) Annals (Oslo), V6, P151
[3]   REDUCING MORTALITY FROM MENINGOCOCCAL DISEASE [J].
BEGG, N .
BRITISH MEDICAL JOURNAL, 1992, 305 (6846) :133-134
[4]   INCIDENCE, SEROGROUPS AND CASE-FATALITY RATE OF INVASIVE MENINGOCOCCAL INFECTIONS IN A SWEDISH REGION 1975-1989 [J].
BERG, S ;
TROLLFORS, B ;
ALESTIG, K ;
JODAL, U .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1992, 24 (03) :333-338
[5]  
BERILD D, 1980, NIPH (National Institute of Public Health) Annals (Oslo), V3, P23
[6]   EFFECT OF OUTER-MEMBRANE VESICLE VACCINE AGAINST GROUP-B MENINGOCOCCAL DISEASE IN NORWAY [J].
BJUNE, G ;
HOIBY, EA ;
GRONNESBY, JK ;
ARNESEN, O ;
HOLSTFREDRIKSEN, J ;
HALSTENSEN, A ;
HOLTEN, E ;
LINDBAK, AK ;
NOKLEBY, H ;
ROSENQVIST, E ;
SOLBERG, LK ;
CLOSS, O ;
ENG, J ;
FROHOLM, LO ;
LYSTAD, A ;
BAKKETEIG, LS ;
HAREIDE, B .
LANCET, 1991, 338 (8775) :1093-1096
[7]  
BOVRE K, 1989, NIPH (National Institute of Public Health) Annals (Oslo), V12, P13
[8]  
BOVRE K, 1980, NIPH (National Institute of Public Health) Annals (Oslo), V3, P9
[9]  
BOVRE K, J INFECT DIS, V4, P669
[10]   EARLY TREATMENT WITH PARENTERAL PENICILLIN IN MENINGOCOCCAL DISEASE [J].
CARTWRIGHT, K ;
REILLY, S ;
WHITE, D ;
STUART, J .
BMJ-BRITISH MEDICAL JOURNAL, 1992, 305 (6846) :143-147